NCT07494058 is a clinical trial of No intervention in Lysosomal Disease, sponsored by Takeda.

Who is sponsoring NCT07494058?

NCT07494058 is sponsored by Takeda.

What drugs are being tested in NCT07494058?

Interventions in NCT07494058: No intervention.

What condition does NCT07494058 study?

NCT07494058 studies Lysosomal Disease.

Is NCT07494058 still recruiting?

NCT07494058 is currently active, enrolled. Last updated 27 March 2026.

Last reviewed 2026-03-27 · How we verify

NCT07494058

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of Home vs Hospital Treatment in People With Fabry, Gaucher or Hunter Conditions in Mexico

Active, enrolled Last updated 27 March 2026

What this trial tests

trial testing No intervention in Lysosomal Disease in 222 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

11 December 2025

Primary endpoint
1 August 2026

1 August 2026

Quick facts

Lead sponsor	Takeda
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	222
Start date	11 December 2025
Primary completion	1 August 2026
Estimated completion	1 August 2026
Sites	1 location across Mexico

Drugs / interventions tested

No intervention

Conditions studied

Lysosomal Disease — all drugs for Lysosomal Disease →

Sponsor

Takeda — full company profile →

Who can join

Eligibility, any sex, with Lysosomal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During the COVID-19 pandemic, home treatment for conditions such as Fabry, Gaucher or Hunter became important because it is easier for people to stick to their treatment if medicines that need to be given as infusion (called intravenous or IV treatment) can be given at home or somewhere close to home. Additionally, many of the hospitals that provide infusions are centralized in Mexico. The main aim of the study is to find out whether people with Fabry, Gaucher or Hunter condition are more likely to continue and follow their treatment properly (called 'treatment adherence') when they receive it at home compared to when they receive it at a hospital. Other aims are to understand the factors that can influence treatment adherence, to learn about any regional differences in Mexico and to understand any medical problems with either treatment (home or hospital). No treatment will be given during this study. Only already existing data will be reviewed during this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other Takeda trials

Trials by the same sponsor.

NCT05669729 — A Survey to Assess Participants', Caregivers', and Nurses' Use and Understanding of Educational Material on Velagluceras · not yet recruiting
NCT07403968 — A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease · Phase 2 · not yet recruiting
NCT07293364 — A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary Angioedema · NA · not yet recruiting
NCT07218393 — A Study About the Diagnosis and Management of Hereditary Angioedema (HAE) in Egypt · not yet recruiting
NCT07445087 — A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07494058 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Takeda
Last refreshed: 27 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07494058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing